Drug Price Increases Fall for Third Consecutive Year

After meeting with lawmakers in January, pharmaceutical leaders have again dropped price increases for the third year in a row. In 2017, only 5.5% of drugs rose by more than 10%, a 5% decrease from 2016 and a 10% decrease from 2015. These decreases have stalled drug...

Pfizer Releases Biosimilar Data, Rivals J&J

At the six-week mark of its fifty-four-week study, Pfizer released data for its biosimilar, Inflectra as a treatment for Crohn’s disease. Previously, Inflectra was approved to treat moderate to severe Crohn’s disease but did not have Crohn’s-specific data. With its...